Skip to content

A pilot study to evaluate the therapeutic efficacy of kurosani ommumsathu (internal) in the management ofthookaminmai (insomnia)

A Pilot study to evaluate the therapeutic efficacy of Kurosani ommumsathu (internal Medicine) in the management of Thookaminmai (Insomnia)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/04/004520
Enrollment
10
Registered
2014-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- THOOKAMINMAI(INSOMNIA)

Interventions

Intervention1: KUROSANI OMMUM SATHU: 65 mg to 320 mg of KUROSANI OMMUM SATHU will be administered orally at bed time (night)with milk for 48 days. Control Intervention1: nil: nil

Sponsors

NATIONAL INSTITUTE OF SIDDHA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age: between 20 years and 65 years • Sex: Both male and female • Stress • Disturbed sleep cycles • Repeated nightmares or panic attacks during sleep. • Lack of interest in day to day activities • Thoughts of extreme guilt • Diminished abilty to think or concentrate • Willing to participate in trial and signing consent by fulfilling the conditions of proforma • Willing to give blood sample for analysis for laboratory investigations

Exclusion criteria

Exclusion criteria: cardiac diseases Malignancy Drug addicts Patients with any other serious illness Pregnanacy and lactation. Patients taking anti depressant drugs

Design outcomes

Primary

MeasureTime frame
Sleep is determined by Pittsburgh Insomnia Rating Scale.Timepoint: Before and After treatment

Secondary

MeasureTime frame
Reduction in the symptoms of InsomniaTimepoint: 48days

Countries

India

Contacts

Public ContactDR V MAHALAKSHMI

NATIONAL INSTITUTE OF SIDDHA

gtsiddha60@gmail.com8056074770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026